Just in case you haven't heard the news, 'There have been “very exciting” developments over the last decade in the treatment of CLL, Dr Kanti Rai (of CLL Rai staging fame) told HemOnc Today': healio.com/hematology-oncol...
Neil
Ibrutinib, idelalisib, venetoclax provide ‘ver... - CLL Support
Ibrutinib, idelalisib, venetoclax provide ‘very exciting developments’ in CLL - Dr Kanti Rai
AussieNeilPartnerAdministrator
Written by
AussieNeil
Partner
To view profiles and participate in discussions please or .
Read more about...
1 Reply
•
Not what you're looking for?
You may also like...
Dr. Kanti Rai on the Future of CLL Therapy
Friends,
This week we have posted an interview with one and only Dr. Kanti Rai when he sat down to...
Vaccines, Ibrutinib toxicity,Dr. Rai on a cure, Dr Ghia on TP563 testing and ERIC
I warned that our website's pages would be busy through the end of the year.
I tried to synthesize...
Frontline Venetoclax/Obinutuzumab Approved in Europe for CLL
In some welcome good news, "The European Commission has approved a fixed-dose combination of...
Dr. Wierda on the paradigm shift in CLL.
Dr. Wierda is my doctor and in the short time I met with him in 2017, I didn’t get the impression...
Stopping ibrutinib and imaging in CLL
Hi,
I stopped ibrutinib after almost 8 years. I discuss my thoughts and emotions around saying...
Related Posts
- Dr Peter Hillmen of Leeds, UK discusses the place for Idelalisib in CLL treatment (Patient Power Video)
- ASH 2013: Dr. John Pagel Speculates on the Future of CLL Therapies including the late breaking data on Idelalisib
Role of RITUXIMAB in CLL treatment in combination with Venetoclax- ASH 2018: Dr. Lindsey Roeker, on real world use of venetoclax for CLL (chronic lymphocytic leukemia)
Exciting times in CLL: an ASCO 2013 interview with Dr Susan O’Brien
